Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …

Bipolar depression (BD-D) is both common and incredibly challenging to treat. Even treated
individuals with BD-D experience depression approximately 19% of the time, and …

Polypharmacology is nowadays considered an increasingly crucial aspect in discovering
new drugs as a number of original single-target drugs have been performing far behind …

Since their first application in psychiatry seventy years ago, antipsychotic drugs, besides
schizophrenia, have been widely used in the treatment of mood disorders. Such an …

Non-invasive nose-to-brain delivery presents a competitive strategy for effective drug
targeting. This strategy can potentially evade the blood-brain barrier (BBB) depending on …

The topic of this narrative review is mood stabilizers. First, the author's definition of mood-
stabilizing drugs is provided. Second, mood-stabilizing drugs meeting this definition that …

Introduction People with severe mental illness have poor cardiometabolic health. Commonly
used antidepressants and antipsychotics frequently lead to weight gain, which may further …

Schizophrenia, affecting approximately 1% of the global population, necessitates effective
treatments like Lurasidone (LUR). However, the accurate separation of LUR from its …

Introduction Pharmacotherapy of depression is characterized by the delayed onset of action,
chronic treatment requirements, and insufficient effectiveness. Ketamine, with its rapid action …

Background: Health-related quality of life (H-QoL) is a critical measure in bipolar disorder
(BD). Recent trials using virtual reality (VR) have shown potential in improving H-QoL …